TheraRadar
Clinical-Stage Companies / Hanlim Pharm.

Hanlim Pharm.

Pre-Approval PRO BETA
34
Total Trials
12
Phase 3
4
Phase 2
2
Recruiting
265
Score

Pipeline by Phase

Phase 3
12
Phase 2
4
Phase 1
16

Therapeutic Focus

Healthy Male Subjects Acute Bronchitis Healthy Male Volunteers Primary Hypercholesterolemia Breast Diseases

Clinical Trials (34)

NCT07552389 Phase 3 RECRUITING

Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus

Started: 12/18/2025

NCT04606329 Phase 3 COMPLETED

To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3)

Started: 7/20/2020

NCT01768520 Phase 3 COMPLETED

Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee

Started: 7/2/2012

NCT03654196 Phase 3 COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients

Started: 3/16/2018

NCT03655210 Phase 3 COMPLETED

To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients

Started: 2/7/2017

NCT01768312 Phase 3 COMPLETED

Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group

Started: 8/23/2012

NCT03317301 Phase 3 COMPLETED

Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus

Started: 5/17/2017

NCT03571087 Phase 3 COMPLETED

Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia

Started: 9/1/2014

NCT03618797 Phase 3 COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

Started: 11/1/2015

NCT02229955 Phase 3 COMPLETED

Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease

Started: 12/1/2013

NCT01470053 Phase 3 COMPLETED

Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis

Started: 3/1/2011

NCT01806792 Phase 3 COMPLETED

Post-menopausal Women Osteoporosis(Phase III)

Started: 11/1/2009

NCT06434792 Phase 2 RECRUITING

Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease

Started: 6/1/2023

NCT03743259 Phase 2 COMPLETED

To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions

Started: 5/29/2018

NCT03309800 Phase 2 COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients

Started: 3/29/2017

NCT02250027 Phase 2 COMPLETED

A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on)

Started: 3/1/2014

NCT06642987 Phase 1 COMPLETED

Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.

Started: 10/23/2023

NCT06475872 Phase 1 COMPLETED

Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects

Started: 11/20/2023

NCT04667624 Phase 1 COMPLETED

Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers

Started: 2/29/2020

NCT04114461 Phase 1 COMPLETED

Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers

Started: 11/6/2019

NCT03650608 Phase 1 COMPLETED

A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of HL217 Eye Drop in Healthy Male Subjects

Started: 8/1/2016

NCT03648346 Phase 1 COMPLETED

A Dose-escalation Clinical Trial After Multiple Dosing of HL217 Eye Drop in Healthy Male Subjects

Started: 4/4/2018

NCT03648333 Phase 1 COMPLETED

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)

Started: 12/1/2013

NCT02682745 Phase 1 COMPLETED

Single Dosing Clinical Trial of HL151

Started: 1/15/2016

NCT02686294 Phase 1 COMPLETED

Repeated Dosing Clinical Trial of HL151

Started: 2/16/2016

NCT03278470 Phase 1 COMPLETED

A Single Ascending Dose Clinical Trial to Find the Maximum Tolerable Dose of HL237 in Healthy Male Subject

Started: 6/26/2017

NCT01549743 Phase 1 COMPLETED

The Pharmacokinetic Interaction Between Celecoxib and Rebamipide

Started: 5/9/2012

NCT01819779 Phase 1 COMPLETED

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)

Started: 3/1/2013

NCT02250976 Phase 1 COMPLETED

The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca

Started: 9/1/2014

NCT01767610 Phase 1 COMPLETED

Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin

Started: 1/1/2013

NCT02955498 Phase 1 COMPLETED

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects

Started: 4/1/2014

NCT01652339 Phase 1 COMPLETED

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects

Started: 7/1/2012

NCT01675297 Phase 4 COMPLETED

Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis

Started: 7/4/2011

NCT01904110 Phase 4 COMPLETED

To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women

Started: 12/1/2012

Drug Candidates

Vonoprazan Test 20mg Vonoprazan Reference 20mg Crecheck Tablet 2.5 mg Crestor Tablet 5 mg Bronpass Tab. LuminoMark inj.(Conc. for fluorescence) Charcotrace Inj. Twynsta LodineT HL-TOF tab. 5mg
Activity Status: Active
Last Trial Started: 12/18/2025
Last Trial Ended: 2/23/2024
Trials (12 months): 1
Completed Trials: 32
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.